ConductScience.org, home

Paper21813640

Structural basis for matrix metalloproteinase-2 (MMP-2)-selective inhibitory action of β-amyloid precursor protein-derived inhibitor.

Hashimoto H and 5 others. J Biol Chem, 2011. Cited by 44 papers, by iCite.

Cite this record

ConductScience Library. Structural basis for matrix metalloproteinase-2 (MMP-2)-selective inhibitory action of β-amyloid precursor protein-derived inhibitor. Papers, record 21813640. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21813640

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Structural basis for matrix metalloproteinase-2 (MMP-2)-selective inhibitory action of β-amyloid precursor protein-derived inhibitor.
PubMed
Journal
J Biol Chem
PubMed
Year
2011
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
44
iCite
Relative citation ratio, by iCite
1.38
iCite
Revised in PubMed
2021-10-20
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hashimoto HHiroshi
2Takeuchi TTomoka
3Komatsu KKyoko
4Miyazaki KKaoru
5Sato MMamoru
6Higashi SShouichi

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Matrix Metalloproteinase 2Major topic
Matrix Metalloproteinase InhibitorsMajor topic
ProteinsMajor topic
Amino Acid Sequence
Catalytic Domain
Crystallography, X-Ray
Humans
Models, Molecular
Molecular Sequence Data
Mutant Proteins
Protein Binding
Protein Structure, Secondary

Source PubMed

Download CSV of topics

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119551841Timp-2 binding with cellular MT1-MMP stimulates invasion-promoting MEK/ERK signaling in cancer cells.Int J Cancer2010https://conductscience.org/library/papers/19551841PubMed
29724659Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.EMBO J1998https://conductscience.org/library/papers/9724659PubMed
312032297Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2.Proc Natl Acad Sci U S A2002https://conductscience.org/library/papers/12032297PubMed
412586836Identification of a region of beta-amyloid precursor protein essential for its gelatinase A inhibitory activity.J Biol Chem2003https://conductscience.org/library/papers/12586836PubMed
527754618Processing of X-ray diffraction data collected in oscillation mode.Methods Enzymol1997https://conductscience.org/library/papers/27754618PubMed
618955490Identification of amino acid residues of matrix metalloproteinase-7 essential for binding to cholesterol sulfate.J Biol Chem2008https://conductscience.org/library/papers/18955490PubMed
78479521A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor.Nature1993https://conductscience.org/library/papers/8479521PubMed
89288970Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1.Nature1997https://conductscience.org/library/papers/9288970PubMed
911278347The 1.8-A crystal structure of a matrix metalloproteinase 8-barbiturate inhibitor complex reveals a previously unobserved mechanism for collagenase substrate recognition.J Biol Chem2001https://conductscience.org/library/papers/11278347PubMed
1017991754Tissue inhibitor of metalloproteinases-2 binding to membrane-type 1 matrix metalloproteinase induces MAPK activation and cell growth by a non-proteolytic mechanism.J Biol Chem2008https://conductscience.org/library/papers/17991754PubMed
119390552ECM and cell surface proteolysis: regulating cellular ecology.Cell1997https://conductscience.org/library/papers/9390552PubMed
121691865Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing.Science1990https://conductscience.org/library/papers/1691865PubMed
1311990853New functions for the matrix metalloproteinases in cancer progression.Nat Rev Cancer2002https://conductscience.org/library/papers/11990853PubMed
141279136Association and release of the amyloid protein precursor of Alzheimer's disease from chick brain extracellular matrix.J Neurosci1992https://conductscience.org/library/papers/1279136PubMed
158137810The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity.EMBO J1994https://conductscience.org/library/papers/8137810PubMed
169249047
1.8-A crystal structure of the catalytic domain of human neutrophil collagenase (matrix metalloproteinase-8) complexed with a peptidomimetic hydroxamate primed-side inhibitor with a distinct selectivity profile.
Eur J Biochem1997https://conductscience.org/library/papers/9249047PubMed
1716498445Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.Nat Rev Cancer2006https://conductscience.org/library/papers/16498445PubMed
1816405877Structure and function of matrix metalloproteinases and TIMPs.Cardiovasc Res2006https://conductscience.org/library/papers/16405877PubMed
1910818225The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3.FEBS Lett2000https://conductscience.org/library/papers/10818225PubMed
202881207The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor.Nature1987https://conductscience.org/library/papers/2881207PubMed

See all 36 referencesDownload CSV of references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.

PMIDTitleJournalYearIn PapersSource
41478668Kidney-specific delivery of a matrix metalloproteinase-2 inhibitory peptide fused to elastin-like polypeptide reduces proteinuria and renal fibrosis in a model of salt-sensitive hypertension.J Pharmacol Exp Ther2025https://conductscience.org/library/papers/41478668PubMed
41069169Recent advances in the design and development of small-molecule MMP-2 inhibitors.Future Med Chem2025https://conductscience.org/library/papers/41069169PubMed
40265458Matrix Metalloproteinases in Glioma: Drivers of Invasion and Therapeutic Targets.BioTech (Basel)2025https://conductscience.org/library/papers/40265458PubMed
40164643A multifaceted examination of the action of PDE4 inhibitor rolipram on MMP2/9 reveals therapeutic implications.Sci Rep2025https://conductscience.org/library/papers/40164643PubMed
39023545Unveiling esophageal cancer treatment mechanisms: network pharmacology and molecular docking of Physcion.Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/39023545PubMed
36997589Utilizing genetic code expansion to modify N-TIMP2 specificity towards MMP-2, MMP-9, and MMP-14.Sci Rep2023https://conductscience.org/library/papers/36997589PubMed
35013344Harnessing protein folding neural networks for peptide-protein docking.Nat Commun2022https://conductscience.org/library/papers/35013344PubMed
33373399Discovery of potent and specific inhibitors targeting the active site of MMP-9 from the engineered SPINK2 library.PLoS One2020https://conductscience.org/library/papers/33373399PubMed
28299742Virtual High-Throughput Screening for Matrix Metalloproteinase Inhibitors.Methods Mol Biol2017https://conductscience.org/library/papers/28299742PubMed
25925871A study on quantitative structure-activity relationship and molecular docking of metalloproteinase inhibitors based on L-tyrosine scaffold.Daru2015https://conductscience.org/library/papers/25925871PubMed
25375834Exploration of the zinc finger motif in controlling activity of matrix metalloproteinases.J Phys Chem B2014https://conductscience.org/library/papers/25375834PubMed
25273674Functional characterisation of a novel mutation affecting the catalytic domain of MMP2 in siblings with multicentric osteolysis, nodulosis and arthropathy.J Hum Genet2014https://conductscience.org/library/papers/25273674PubMed
25050378Matrix metalloproteinases and their multiple roles in Alzheimer's disease.Biomed Res Int2014https://conductscience.org/library/papers/25050378PubMed
25032844Alzheimer's disease--a panorama glimpse.Int J Mol Sci2014https://conductscience.org/library/papers/25032844PubMed
23913860Crystal structure of full-length human collagenase 3 (MMP-13) with peptides in the active site defines exosites in the catalytic domain.FASEB J2013https://conductscience.org/library/papers/23913860PubMed
23894097Strategic targeting of multiple water-mediated interactions: a concise and rational structure-based design approach to potent and selective MMP-13 inhibitors.ChemMedChem2013https://conductscience.org/library/papers/23894097PubMed
23395821Molecular design of a highly selective and strong protein inhibitor against matrix metalloproteinase-2 (MMP-2).J Biol Chem2013https://conductscience.org/library/papers/23395821PubMed
23224743Computational insights into the selectivity mechanism of APP-IP over matrix metalloproteinases.J Comput Aided Mol Des2012https://conductscience.org/library/papers/23224743PubMed
23201642Peptide-based selective inhibitors of matrix metalloproteinase-mediated activities.Molecules2012https://conductscience.org/library/papers/23201642PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MMP24313Swiss-Prot's referenceshttps://conductscience.org/library/genes/4313

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21813640

GET https://conductscience.org/api/papers/v1/21813640/references?page=2